Try our beta test site

A Study to Demonstrate the Efficacy of GSK Biologicals' Influenza Vaccine in Adults

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00363870
First received: August 10, 2006
Last updated: March 21, 2017
Last verified: March 2017